Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001089439 | SCV001020850 | benign | Cone-rod dystrophy 13; Leber congenital amaurosis 6 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000878013 | SCV001149117 | uncertain significance | not provided | 2017-07-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001110510 | SCV001267959 | uncertain significance | Cone-rod dystrophy 13 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001110511 | SCV001267960 | uncertain significance | Leber congenital amaurosis 6 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV001110511 | SCV002046023 | likely benign | Leber congenital amaurosis 6 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001110510 | SCV002046034 | likely benign | Cone-rod dystrophy 13 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001110511 | SCV001553339 | likely benign | Leber congenital amaurosis 6 | no assertion criteria provided | clinical testing | The RPGRIP1 p.R812Q variant was identified in two heterozygous probands with Leber congenital amaurosis, as well as one unaffected father (Henderson_2007_PMID: 18055820; Vallespin_2007_PMID: 18055816). The variant was identified in dbSNP (ID: rs190490019) and ClinVar (classified as benign by Invitae and as uncertain significance by Illumina and CeGaT Praxis). The variant was identified in control databases in 269 of 280214 chromosomes (4 homozygous) at a frequency of 0.0009600, and was observed at the highest frequency in the South Asian population in 192 of 30602 chromosomes (4 homozygous) (freq: 0.006274) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.R812 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Prevention |
RCV003930456 | SCV004742440 | likely benign | RPGRIP1-related disorder | 2020-05-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |